Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $145.09 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $97.13 | 2 | $0 (2020) |
| Novo Nordisk Inc | $47.96 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $18.86 | 1 | AstraZeneca Pharmaceuticals LP ($18.86) |
| 2019 | $47.96 | 1 | Novo Nordisk Inc ($47.96) |
| 2018 | $78.27 | 1 | AstraZeneca Pharmaceuticals LP ($78.27) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/04/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $47.96 | General |
| Category: Obesity | ||||||
| 09/05/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $78.27 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 655 | 799 | $743,452 | $74,702 |
| 2022 | 7 | 660 | 801 | $782,900 | $83,279 |
| 2021 | 24 | 1,558 | 2,266 | $736,108 | $114,564 |
| 2020 | 23 | 1,822 | 3,189 | $416,334 | $101,196 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 308 | 318 | $441,702 | $39,248 | 8.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 98 | 143 | $102,674 | $12,540 | 12.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 122 | 209 | $104,500 | $12,258 | 11.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 102 | 104 | $76,648 | $8,736 | 11.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $11,376 | $1,159 | 10.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $6,552 | $760.24 | 11.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 264 | 280 | $389,678 | $41,337 | 10.6% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 108 | 111 | $139,478 | $14,737 | 10.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 103 | 147 | $105,869 | $11,362 | 10.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 92 | 162 | $81,087 | $8,754 | 10.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 65 | 68 | $50,250 | $5,358 | 10.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 17 | 17 | $8,565 | $923.16 | 10.8% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 11 | 16 | $7,973 | $808.26 | 10.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 252 | 480 | $101,760 | $35,626 | 35.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 210 | 216 | $310,932 | $32,477 | 10.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 73 | 74 | $97,599 | $9,964 | 10.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 75 | 110 | $81,521 | $8,608 | 10.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 38 | 42 | $12,012 | $4,577 | 38.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 45 | 83 | $42,537 | $4,517 | 10.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 39 | 40 | $30,548 | $3,096 | 10.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 53 | 166 | $6,806 | $2,304 | 33.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $6,105 | $1,805 | 29.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 135 | 206 | $6,180 | $1,743 | 28.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 119 | 171 | $5,814 | $1,660 | 28.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $5,168 | $1,464 | 28.3% |
About Dr. Charles Pruchno, MD
Dr. Charles Pruchno, MD is a Internal Medicine healthcare provider based in Cedar Rapids, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194762849.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Pruchno, MD has received a total of $145.09 in payments from pharmaceutical and medical device companies, with $18.86 received in 2020. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($145.09).
As a Medicare-enrolled provider, Pruchno has provided services to 4,695 Medicare beneficiaries, totaling 7,055 services with total Medicare billing of $373,740. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Family Medicine
- Location Cedar Rapids, IA
- Active Since 06/01/2006
- Last Updated 05/09/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1194762849
Products in Payments
- Saxenda (Drug) $47.96
- FARXIGA (Drug) $18.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cedar Rapids
Dr. Stanley Mathew, M.d, M.D
Internal Medicine — Payments: $13,615
Dr. Bharat Jenigiri, Md, MD
Internal Medicine — Payments: $8,089
Fadi Yacoub, Md, MD
Internal Medicine — Payments: $7,348
Rezwan Munshi, Md, MD
Internal Medicine — Payments: $2,116
Dr. Amandeep Singh Dhaliwal, M.d, M.D
Internal Medicine — Payments: $2,006
Dr. Susan Schima, M.d, M.D
Internal Medicine — Payments: $1,869